The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global pet supplement market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 6% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Pet supplements assist in providing adequate nutrition to pets depending upon their size and breed. For instance, dogs generally require joint and digestive health supplements, while cats need hairball control supplements. At present, several manufacturers are offering additional supplements for horses, including pre and probiotics for digestive health, enhancing the immune system, maintaining a healthy response, reducing allergy symptoms, and preventing diarrhea.
A considerable increase in the adoption of companion animals on account of inflating disposable incomes and emerging nuclear family trends represent one of the key factors influencing the market growth. Moreover, the increasing prevalence of diseases in animals and the rising concerns among pet parents about the overall well-being of their pets are catalyzing the demand for pet supplements across the globe. These supplements generally include omega-3 fats for the coat; digestive aids to resolve gastric ulcers; biotin, methionine, and zinc to promote hoof growth; and thiamine, magnesium, L-tryptophan, valerian, and chamomile for behavioral effects. Apart from this, due to rising concerns about the quality and safety of pet supplements, governing agencies of numerous countries are enforcing stringent regulations to maintain the efficacy of products. As a result, several manufacturers are funding and collaborating with researchers to perform well-controlled clinical trials to determine the safety and effectiveness of the supplements. This, along with promotional campaigns undertaken by leading players in the industry, is anticipated to bolster the growth of the market in the coming years.
IMARC Group provides an analysis of the key trends in each sub-segment of the global pet supplement market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on pet type, distribution channel, source and application.
Breakup by Pet Type:
Breakup by Distribution Channel:
Breakup by Source:
Breakup by Application:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Ark Naturals Company, Elanco Animal Health Incorporated, Boehringer Ingelheim International GmbH, FoodScience Corporation, Kemin Industries Inc., Nestlé S.A., Novotech Nutraceuticals Inc., NOW Foods, Nutramax Laboratories Inc., VetriScience Laboratories, Virbac and Zoetis Inc.
|Base Year of the Analysis||2020|
|Segment Coverage||Pet Type, Distribution Channel, Source, Application, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Ark Naturals Company, Elanco Animal Health Incorporated, Boehringer Ingelheim International GmbH, FoodScience Corporation, Kemin Industries Inc., Nestlé S.A., Novotech Nutraceuticals Inc., NOW Foods, Nutramax Laboratories Inc., VetriScience Laboratories, Virbac and Zoetis Inc.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at